Tracked deals
3
3 tracked deals across 2021-2023.
Wilmington, Delaware, United States
Phreesia provides technology that helps healthcare organizations understand their patients and equip them with the knowledge, skills, and confidence to succeed, with tools for patient registration, scheduling, payments, and clinical support.
Tracked deals
3
3 tracked deals across 2021-2023.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 2 years
Supporting Data
Phreesia has acquired Access eForms, an electronic forms management and automation provider, to expand its offerings for acute-care hospitals and strengthen integrations with leading EHRs. Access eForms (founded over 20 years ago) processes more than 1.6 billion e-signatures annually and will complement Phreesia's patient intake, outreach and activation platform; Healthcare Growth Partners advised Access eForms on the transaction.
Phreesia has acquired Comsort, Inc. d/b/a MediFind to expand its patient-centered offerings and consumer-facing capabilities. MediFind uses machine learning and proprietary analytics to help patients—particularly those with serious, chronic, and rare conditions—find leading doctors, clinical trials and treatments; MediFind CEO Patrick Howie has joined Phreesia as Vice President of Product Management.
Phreesia, a public healthcare SaaS company based in Raleigh, North Carolina, has acquired Insignia Health, LLC, the exclusive license holder of the Patient Activation Measure (PAM). The deal brings Insignia's patient activation assessment, education and coaching capabilities into Phreesia's patient engagement platform to expand capabilities and scale PAM across Phreesia's provider and payer customers.
Turn tracked acquisition activity into an outreach-ready buyer list.